Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-137555
Filing Date
2020-05-08
Accepted
2020-05-08 16:10:32
Documents
1
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d875117ddefa14a.htm DEFA14A 23806
  Complete submission text file 0001193125-20-137555.txt   24852
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39083 | Film No.: 20860636
SIC: 2836 Biological Products, (No Diagnostic Substances)